Filing Details

Accession Number:
0001447362-20-000299
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-21 16:06:25
Reporting Period:
2020-12-18
Accepted Time:
2020-12-21 16:06:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1447362 Castle Biosciences Inc CSTL () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1239501 J Derek Maetzold C/O Castle Biosciences, Inc.
820 S. Friendswood Drive, Suite 201
Friendswood TX 77546
Pres. & Chief Exec. Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-12-18 4,129 $62.20 1,289,373 No 4 S Direct
Common Stock Disposition 2020-12-18 1,521 $63.01 1,287,852 No 4 S Direct
Common Stock Disposition 2020-12-18 500 $64.21 1,287,352 No 4 S Direct
Common Stock Disposition 2020-12-18 100 $65.02 1,287,252 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 159,329 Indirect By trust
Footnotes
  1. These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2020.
  2. This transaction was executed in multiple trades at prices ranging from $61.66 to $62.62, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $62.74 to $63.42, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $63.86 to $64.36, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. Held by the DJM Grantor Retained Annuity Trust No. 1, or the Maetzold Trust. The Reporting Person is a trustee of the Maetzold Trust.